Cempra, Inc. has received $-0.57 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 10 Financial Advisor in the Stock Trading Firms. Among 10 Analysts, Bottom line EPS Estimate for the current quarter is $-0.78 while the top line estimate is $-0.31 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at -19.58%.
Cempra, Inc. reported better than expected with a surprise EPS of 3.12% or $0.02 during its most recent quarterly earnings. The Actual EPS was $-0.62 compared to the Estimated EPS of $-0.64.
In the last quarter, Cempra, Inc. reported Annual Earnings of $-0.62. Based on the filings, last years Annual Earnings was, $-2.09. In the last Quarter, CEMP reported a surprise Earnings per Share of 3.12% . The consensus estimate for current quarter is $-0.57 and for the current fiscal year, the estimate is $-2.34. For the Next fiscal year, the estimate is $-2.07 based on the consensus.
Cempra, Inc. (NASDAQ:CEMP) stock ended Tuesday session in the red zone in a volatile trading. The stock closed down 0.05 points or 1.56% at $3.15 with 1,389,354 shares getting traded. Post opening the session at $3.1, the shares hit an intraday low of $3.1 and an intraday high of $3.35 and the price was in this range throughout the day. The company has a market cap of $165 million and the number of outstanding shares has been calculated to be 52,381,530 shares. The 52-week high of Cempra, Inc. (NASDAQ:CEMP) is $26.95 and the 52-week low is $2.55.
Cempra Holdings, LLC is a pharmaceutical company engaged in developing antibiotics for the treatment of bacterial infectious diseases. It focuses on developing antibiotics for treating respiratory tract, skin and skin structure infections and to target the growing problem of antimicrobial resistance. Cempra Holdings, LLC is headquartered in Chapel Hill, North Carolina.